HA-based systems effectively targeted CD44, overexpressing CRC phenotypes, key drivers of stemness and metastasis, showing enhanced tumor accumulation, reduced migration, and selective cytotoxicity compared with free apigenin [70]. This evidence concerns the gene CD44 and neoplasm.